GSK plans to move vaccine R&D center from Rockville, Md. to the Boston area
After calling Rockville, Maryland home for more than eight years, pharma giant GSK is planning to move its vaccine and infectious disease R&D teams northeast to Cambridge.
After calling Rockville, Maryland home for more than eight years, pharma giant GSK is planning to move its vaccine and infectious disease R&D teams northeast to Cambridge.
